Quarterly report pursuant to Section 13 or 15(d)

Organization and Basis of Presentation (Details Narrative)

v3.23.2
Organization and Basis of Presentation (Details Narrative) - USD ($)
$ / shares in Units, $ in Millions
1 Months Ended 6 Months Ended 12 Months Ended
Aug. 17, 2021
Jun. 30, 2023
Dec. 31, 2022
Mar. 31, 2023
Accumulated deficit   $ (49.5)    
Common stock shares, par value   $ 0.0001 $ 0.0001  
Cash and cash equivalents   $ 8.4    
Net Cash Used In Operation   $ 3.5 $ 8.8  
Sale of stock 160,714      
Warrant exercise price   $ 112.00    
Warrant exercise price       $ 0.0001
Initial Public Offering [Member]        
Common stock shares, par value $ 0.0001      
Warrants to purchase one share of common stock 160,714      
Warrant exercise price $ 112.00      
Combined Offering Price $ 112.00      
Warrants issued 24,106 184,820    
Option exercise price $ 112.00      
Gross Proceeds from warrants purchase of common stock $ 15.4 $ 1.8    
Issuance costs $ 2.6